CompletedNCT01998139

Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis

Studying Antisynthetase syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Weill Medical College of Cornell University
Principal Investigator
Ronald G Crystal, MD
Weill Medical College of Cornell University
Enrollment
137 enrolled
Eligibility
18 years · All sexes
Timeline
20132019

Study locations (2)

Collaborators

Hamad Medical Corporation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01998139 on ClinicalTrials.gov

Other trials for Antisynthetase syndrome

Additional recruiting or active studies for the same condition.

See all trials for Antisynthetase syndrome

← Back to all trials